Pharmacokinetics and tissue residue profiles of erythromycin in broiler chickens after different routes of administration

Deutsche Tierarztliche Wochenschrift

Volumn 111, Issue 4, 2004, Pages 162-165

  Goudah, A ^a   Abo El Sooud, K ^a   Abd El Aty, A M ^a  

^a Cairo University   (Egypt)

Author keywords

Broiler; Erythromycin; Pharmacokinetics; Tissue residues

Indexed keywords

DRUG RESIDUE; ERYTHROMYCIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BIOASSAY; CHICKEN; COMPARTMENT MODEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG LIVER LEVEL; DRUG MUSCLE LEVEL; DRUG PROTEIN BINDING; DRUG TISSUE LEVEL; HEART; IN VITRO STUDY; KIDNEY; LUNG; MEAN RESIDENCE TIME; MICROBIOLOGY; MICROCOCCUS LUTEUS; NONHUMAN;

ADMINISTRATION, ORAL; ANIMALS; ANTI-BACTERIAL AGENTS; CHICKENS; DRUG RESIDUES; ERYTHROMYCIN; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; RANDOM ALLOCATION;

ANIMALIA; GALLUS GALLUS; MICROCOCCUS; MICROCOCCUS LUTEUS;

EID: 2442566427     PISSN: 03416593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. ALT, D. O., BOLIN, C. A. (1996): Preliminary evaluation of antibacterial agents for treatment of Leptospira interrogans serovar Pomona infection in hamster and swine. Am. J. Vet. Res., 57-59.
2. ANDERSON, R., THERON, A. J., FELDMAN, C. (1996): Membrane stabilizing, anti-inflammatory interactions of macrolides with human neutrophils. Inflamm., 20, 693-705.
3. BABANY, G. LARREY, D., PESSAYRE, D. (1988): Macrolide antibiotics as inducers and inhibitors of cytochrome P450 in experimental animal and man. In: Progress in Drug Metabolism, (GIBSON, G. G., ed.), PP. 61-98. Taylor and Francis, London.
4. BAGGOT, J. D. (1983): Systemic Antimicrobial Therapy in Large Animals. In: BOGAN, J. A., LEES, P., YOXALL, A. T. (eds.): Pharmacological Basis of Large Animal Medicine, Oxford, Blackwell Scientific Publications, pp.45-69.
5. BENNETT, J. V., BRODIE, J. L., BENNER, E. J., KIRBY, W. M. M. (1966): Simplified, accurate method for antibiotic assay of clinical specimens. Applied Microbiol., 14, 170-177.
6. BERGOGNE-BEREZIN, E. (1993): Tissue distribution of dirithromycin: comparison with erythromycin. J. Vet. Pharmacol. Therap., 31, 77-87.
7. BOHLEN, D. M., BURROWS, G. E., CLARKE, C. R., BUR-ROWS, S. L. (1995): Lack of effect of ivermectin on antipyrine and erythromycin disposition in calves. J. Vet. Pharmacol. Therap., 18, 476-478.
8. CRAIG, A. W., SUH, B. (1980): Protein binding and the antibacterial effects: Methods for determination of protein binding. In: LORIAN, V. (ed.): Antibiotics in Laboratory Medicine. Baltimore, Maryland, Williams & Wilkins, pp.265-297.
9. DONEVA, M., BINEVA, I. (1979): Pharmacokinetic and microbiological studies of Pharmachem erythromycin aspirate. Vet. Med. Nauki., 16 (9), 58-64.
10. EWING, P. J., BURROWS, G., MACALLISTER, C., CLARKE, C. (1994): Comparison of oral erythromycin formulations in the horse using pharmacokinetic profiles. J. Vet. Pharmacol. Therap., 17, 17-23.
11. th Ed, New York, Macmillan Publish-ing CO, pp.21 and 1083.
12. GWEN, S. DUTHU (1985): Interspecies correlation of the pharmacokinetics of erythromycin, oleandomycin and tylosin. J. Pharmaceut., Sci., 74, 943-946.
13. HIADDAD, N. S., PEDERSOLI, W. M., RAVIS, W. R., FAZELI, M. H., CARSON, R. L. (1985) Combined pharmacokinetics of gentamicin in pony mares after a single IV and IM administration. Am. J. Vet. Res., 46, 2004-2007.
14. KINOSHITA, T., SON, D. S., SHIMODA, M., KOKUE, E. (1995): Impact of age related alteration of plasma alpha1-acid glycoprotein concentration on erythromycin pharmacokinetics in pigs. Am. J. Vet. Res., 56, 362-365.
15. LAKRITZ, J., WILSON, W. D., JUDITH, E., MIHALYI, B. S. (1999): Comparison of microbiologic and high-performance liquid chromatography assays to determine plasma concentrations, pharmacokinetics, and bioavailability of erythromycin base in plasma of foals after intravenous or intragastric administration. Am. J. Vet. Res., 60, 414-419.
16. ORTIZ DE MONTELLANO, P. R. (1988): Suicide substrates for drug metabolizing enzymes: mechanisms and biological consequences. In: Progress in Drug Metabolism, (GIBSON, G. G., ed.), pp.99-148. Taylor and Francis, London.
17. PRESCOTT, J. F. (1981): The susceptibility of isolates of Corynebacterium equi to antimicrobial drugs. J. Vet. Pharmacol. Therap., 4, 27-31.
18. PRESCOTT, J. F., NICHOLSON, V. M. (1984): The effects of combinations of selected antibiotics on the growth of Corynebacterium equi. J. Vet. Pharmacol. Therap., 7, 61-64.
19. SHEPARD, R. M., FALKNER, F. C. (1990): Pharmacokinetics of azithromycin in rats and dogs. J. Antimicrob. Chemother., 25 Suppl A, 49-60.
20. SIDES, G. D., CERIMELE, B. J., BLACK, H. R., BUSCH, U., DESANTE, K. A. (1993): Pharmacokinetics of dirithromycin. J Antimicrob. Chernother., 31 Suppl. C, 65-75.
21. th Ed, Ames, Iowa, Iowa State University press, pp.39-63.
22. SOBACK, S., ZIV, G., BOGIN, E., COHEN, Z., EARON, Y. (1987): Pharmacokinetic changes of several antibiotics in chickens during induced fatty liver. Res. Vet. Sci., 43 (1), 49-54.
23. YAMAOKA, K., NAKAGAWA, T., UNO, T. (1978): Statistical moments in pharmacokinetics. J. Pharmacokin. Biopharmaceut, 6, 547-558.